Global Antinuclear Antibody (ANA) Test Market Size, Growth Analysis Report, Forecast to 2027

The global ANA test market is anticipated to grow significantly at a CAGR of 12.3% during the forecast period (2021-2027). The ANA test market is segmented based on the product type, test type, disease type, and end-users. Among the test type, the market is segmented into indirect immunofluorescence, enzyme-linked immunosorbent assay (ELISA), and multiplex testing. Besides, the key companies across the globe are adopting different business strategies including expanding their geographic presence, R&D activities, new product approvals, mergers & acquisitions, partnerships, and collaborations to increase market share.

(Get 15% Discount on Buying this Report)

Get Report Sample Copy @ https://www.omrglobal.com/request-sample/antinuclear-antibody-ana-test-market

Further, in February 2019, Grifols, a producer of plasma-derived medicines and one of the leaders in the development of innovative diagnostic solutions, has announced that the US Food and Drug Administration (FDA) approved the Procleix Babesia assay, a qualitative assay for the detection of the ribosomal RNA from 4 Babesia species (B. microti, B. duncani, B. divergens, B. venatorum) in samples of individual or around 16 pooled lysed specimens from human donors, including donors of whole blood and blood components for transfusion. The assay is utilizing Nucleic Acid Testing (NAT) for blood screening.

A Full Report of Global Antinuclear Antibody (ANA) Test Market is Available at: https://www.omrglobal.com/industry-reports/antinuclear-antibody-ana-test-market

In Addition, in June 2018, Grifols' latest diagnostic examinations for Antineutrophil Cytoplasmic Antibodies (ANCA)-associated vasculitis and lupus were approved by the US FDA. These tests enabled labs to use immunofluorescence assays to standardize and speed up diagnosis. The FDA's recent approvals would enable laboratories to diagnose autoimmune diseases like lupus, scleroderma, and vasculitis more accurately and efficiently. Apart from it, in October 2020, ZEUS Scientific has announced the received approval from the US Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) for its in vitro ELISA diagnostic test for the qualitative detection of IgG antibodies to the SARS-CoV-2 virus in human serum and plasma. This test is readily available in all clinical laboratories since it is in stock. However, the various approvals by the US FDA for the assays, diagnostics test, and others of the key players are to propel the growth of the global ANA test market.

Global ANA Test Market Report Segment

By Product Type

Assay Kits & Reagents
Antinuclear Antibody Test System
Antinuclear Antibody Test Software

By Test Type

Indirect Immunofluorescence
Enzyme-Linked Immunosorbent Assay (ELISA)
Multiplex Testing

By Disease Type

Systemic Lupus Erythematosus
Sjögren’s Syndrome
Rheumatoid Arthritis
Scleroderma
Others (Addison Disease And Pulmonary Fibrosis)

By End-User

Hospitals
Clinical Laboratories

Global ANA Test Market Report Segment by Region

North America

United States
Canada

Europe

UK
Germany
Italy
Spain
France
Rest of Europe

Asia-Pacific

China
India
Japan
South Korea
Rest of Asia-Pacific

Rest of the World

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/antinuclear-antibody-ana-test-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.